Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Jul;44(7):1317-21.
doi: 10.1023/a:1026675012864.

Pancreatic Supplements Reduce Symptomatic Response of Healthy Subjects to a High Fat Meal

Affiliations
Clinical Trial

Pancreatic Supplements Reduce Symptomatic Response of Healthy Subjects to a High Fat Meal

F Suarez et al. Dig Dis Sci. .

Abstract

In a double-blind, crossover study, we determined whether microencapusulated pancreatic enzymes reduce postprandial symptoms experienced by healthy volunteers after ingestion of a high calorie, high fat meal. At 7 AM, 18 subjects ingested 185 g of cookies (1196 calories and 72 g of fat) with three pancrelipase capsules or a placebo. The severity of gastrointestinal symptoms and flatus passages were recorded for 15-17 hr, and end-alveolar samples were obtained hourly for 10 hr. Ingestion of pancreatic supplements was associated with a significant (P = 0.049) reduction in bloating over the entire recording period, and with significant reductions in bloating, gas, and fullness during the dinner to bedtime period. Pancreatic supplements had no significant effect on breath H2 or CH4 concentration. The finding that pancreatic supplements reduce postprandial symptoms in healthy subjects suggests that these supplements also might be beneficial in irritable bowel syndrome.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles

References

    1. Ann Intern Med. 1992 Jun 15;116(12 Pt 1):1009-16 - PubMed
    1. Gastroenterology. 1984 Sep;87(3):578-85 - PubMed
    1. J Clin Invest. 1970 Aug;49(8):1558-64 - PubMed
    1. N Engl J Med. 1981 Apr 9;304(15):891-2 - PubMed
    1. Gastroenterology. 1991 Jul;101(1):175-9 - PubMed

Publication types

LinkOut - more resources

Feedback